Zidovudine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals. The primary component is Zidovudine.
Product ID | 31722-509_17d3e8e2-7532-48ea-aa17-cef1c947e516 |
NDC | 31722-509 |
Product Type | Human Prescription Drug |
Proprietary Name | Zidovudine |
Generic Name | Zidovudine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-01-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090092 |
Labeler Name | Camber Pharmaceuticals |
Substance Name | ZIDOVUDINE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2008-04-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090092 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-04-25 |
Ingredient | Strength |
---|---|
ZIDOVUDINE | 300 mg/1 |
SPL SET ID: | ca9f0c57-fc8b-4da4-a987-0fc52b7fd4f4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-6106 | Zidovudine | zidovudine |
0527-1905 | Zidovudine | Zidovudine |
21695-369 | Zidovudine | ZIDOVUDINE |
31722-509 | Zidovudine | Zidovudine |
52343-044 | Zidovudine | Zidovudine |
52343-045 | Zidovudine | Zidovudine |
53104-0100 | Zidovudine | zidovudine |
53104-0101 | Zidovudine | Zidovudine |
53104-0105 | zidovudine | zidovudine |
53808-0812 | Zidovudine | ZIDOVUDINE |
53808-0878 | Zidovudine | zidovudine |
57237-241 | Zidovudine | Zidovudine |
65862-024 | Zidovudine | Zidovudine |
65862-048 | Zidovudine | Zidovudine |
65862-107 | Zidovudine | Zidovudine |
70518-1656 | Zidovudine | Zidovudine |
49702-211 | RETROVIR | zidovudine |
49702-212 | RETROVIR | zidovudine |
49702-213 | RETROVIR | zidovudine |